CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Open-Label, Single-Arm, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, Pharmacokinetic, and Antitumor Activity of E-602 as a Single Agent and in Combination With Cemiplimab in Patients With Advanced Cancers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05259696
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:25.693885+00:00
Published At: 2025-08-20T00:00:00+00:00
Record Updated At: 2025-08-20
Results Posted At: 2025-08-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Oncology", "Melanoma", "Ovarian Cancer", "NSCLC", "Non Small Cell Lung Cancer", "Colorectal Cancer", "Pancreatic Cancer", "Cancer", "CRC", "Colon Cancer", "Breast Cancer", "Gastric Cancer", "EGJ", "Esophagogastric Junction Cancer", "Head and Neck Cancer", "Urothelial Cancer", "Bladder Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-08-20"
protocolSection.identificationModule.nctId: "NCT05259696"
protocolSection.identificationModule.officialTitle: "A Phase 1/2, Open-Label, Single-Arm, Dose-Escalation and Dose-Expansion Study of the Safety, Tolerability, Pharmacokinetic, and Antitumor Activity of E-602 as a Single Agent and in Combination With Cemiplimab in Patients With Advanced Cancers"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-08-20"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.